NeuroPace Market Cap

NeuroPace has a market cap or net worth of $368.20 million as of April 26, 2024. Its market cap has increased by 217.41% in one year.

Market Cap

368.20M

Enterprise Value

374.02M

1-Year Change

217.41%

Ranking

#3149

Market Cap Chart

Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $368.20M, a decrease of -6.38%. That is a compound annual growth rate of -2.17%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	384.40M	-3.20%
Apr 23, 2024	397.10M	0.08%
Apr 22, 2024	396.80M	0.13%
Apr 19, 2024	396.30M	-0.13%
Apr 18, 2024	396.80M	1.82%
Apr 17, 2024	389.70M	-2.09%
Apr 16, 2024	398.00M	4.79%
Apr 15, 2024	379.80M	-0.76%
Apr 12, 2024	382.70M	-6.91%
Apr 11, 2024	411.10M	-0.12%
Apr 10, 2024	411.60M	-4.41%
Apr 9, 2024	430.60M	-0.90%
Apr 8, 2024	434.50M	5.87%
Apr 5, 2024	410.40M	14.00%
Apr 4, 2024	360.00M	2.68%
Apr 3, 2024	350.60M	-3.28%
Apr 2, 2024	362.50M	-6.52%
Apr 1, 2024	387.80M	3.66%
Mar 28, 2024	374.10M	-3.16%
Mar 27, 2024	386.30M	2.25%
Mar 26, 2024	377.80M	2.30%
Mar 25, 2024	369.30M	-6.20%
Mar 22, 2024	393.70M	2.42%
Mar 21, 2024	384.40M	-0.57%
Mar 20, 2024	386.60M	1.42%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
MultiPlan	374.30M
Surmodics	372.56M
Biomea Fusion	370.65M
Pacific Biosciences of California	369.77M
Pulse Biosciences	369.46M
ADC Therapeutics	367.69M
Cartesian Therapeutics	365.20M
DocGo	363.56M

Market Cap Rankings